Clinical efficacy of dacomitinib in rechallenge setting for patients with epidermal growth factor receptor mutant non-small cell lung cancer: A multicenter retrospective analysis (TOPGAN2020-02).
Thorac Cancer
; 13(10): 1471-1478, 2022 05.
Article
in En
| MEDLINE
| ID: mdl-35415873
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Non-Small-Cell Lung
/
Quinazolinones
/
Lung Neoplasms
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
Thorac Cancer
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: